A novel peroxisome proliferator-activated receptor delta antagonist, SR13904, has anti-proliferative activity in human cancer cells (Q39820536)

14 September 2017

A novel peroxisome proliferator-activated receptor delta antagonist, SR13904, has anti-proliferative activity in human cancer cells (English)

1 reference

14 September 2017

Nurulain T Zaveri

1

1 reference

14 September 2017

Barbara G Sato

2

1 reference

14 September 2017

Faming Jiang

3

1 reference

14 September 2017

Joy Calaoagan

4

1 reference

14 September 2017

Keith R Laderoute

5

1 reference

14 September 2017

Brian J Murphy

6

1 reference

14 September 2017

7 July 2009

1 reference

Cancer Biology and Therapy

14 September 2017

1 reference

14 September 2017

8

1 reference

14 September 2017

13

1 reference

14 September 2017

1252-1261

1 reference

Activation of peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) increases the expression of prostaglandin E2 receptor subtype EP4. The roles of phosphatidylinositol 3-kinase and CCAAT/enhancer-binding protein beta

14 September 2017

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1074/JBC.M507617200

A novel positive feedback loop between peroxisome proliferator-activated receptor-delta and prostaglandin E2 signaling pathways for human cholangiocarcinoma cell growth.

1 reference

3 January 2024

https://opencitations.net/index/api/v1/citations/10.1074/JBC.M600135200

Identifiers

DOI

10.4161/CBT.8.13.8691

1 reference

14 September 2017

1 reference